(Q44675171)

5 December 2017

Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia (English)

1 reference

5 December 2017

1 reference

Krajinovic M

1

1 reference

5 December 2017

Lemieux-Blanchard E

2

1 reference

5 December 2017

Chiasson S

3

1 reference

5 December 2017

Primeau M

4

1 reference

5 December 2017

Costea I

5

1 reference

5 December 2017

Moghrabi A

6

1 reference

5 December 2017

1 January 2004

1 reference

The Pharmacogenomics Journal

5 December 2017

1 reference

5 December 2017

4

1 reference

5 December 2017

1

1 reference

5 December 2017

66-72

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500224

5 December 2017

0 references

cites work

Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

A Polymorphism, R653Q, in the Trifunctional Enzyme Methylenetetrahydrofolate Dehydrogenase/Methenyltetrahydrofolate Cyclohydrolase/Formyltetrahydrofolate Synthetase Is a Maternal Genetic Risk Factor for Neural Tube Defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

The pharmacology and clinical use of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Methenyltetrahydrofolate synthetase regulates folate turnover and accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Molecular cloning, characterization, and regulation of the human mitochondrial serine hydroxymethyltransferase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Mitochondrial NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is essential for embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

The influence of cyclin D1 (CCND1) 870A>G polymorphism and CCND1-thymidylate synthase (TS) gene-gene interaction on the outcome of childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Rapid Detection of CYP1A1, CYP2D6, and NAT Variants by Multiplex Polymerase Chain Reaction and Allele-Specific Oligonucleotide Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

inferred from DOI database lookup

7 January 2021

based on heuristic

Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

inferred from DOI database lookup

7 January 2021

based on heuristic

Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500224

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.TPJ.6500224

1 reference

Dimensions Publication ID

5 December 2017

0 references

1 reference